In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells
British Journal of Pharmacology · 2023
DOI: 10.1111/bph.16088 ↗At a glance
Journal article in British Journal of Pharmacology, 2023. Written by Mark F Bird and 7 co-authors. Institution: Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Leicester, UK. Major MEDLINE topics: Receptors, Opioid, Sepsis. Cited 3 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY 4.0). Funded by: Biotechnology and Biological Sciences Research Council.
Topics: Sepsis
Abstract (original language)
Background and Purpose In animal models of sepsis, increased activation of the Nociceptin/Orphanin FQ (N/OFQ) receptor NOP is associated with mortality and NOP antagonists improved survival. We have explored the role of the N/OFQ‐NOP system in freshly isolated volunteer human B‐ and T‐cells incubated with lipopolysaccharide (LPS) and peptidoglycan G (PepG) as a model of in vitro sepsis. Experimental Approach B‐ and T‐cell NOP expression was measured using the NOP fluorescent probe N/OFQ ATTO594 , N/OFQ content was measured using immunofluorescence, N/OFQ release was tracked using a CHO hNOPGαiq5 biosensor assay and NOP function was measured using transwell migration and cytokine/chemokine release using a 25‐plex assay format. Cells were challenged with LPS/PepG. Key Results CD19‐positive B‐cells bound N/OFQ ATTO594 ; they also contain N/OFQ. Stimulation with CXCL13/IL‐4 increased N/OFQ release. N/OFQ trended to reduced migration to CXCL13/IL‐4. Surface NOP expression was unaffected by LPS/PepG, but this treatment increased GM‐CSF release in an N/OFQ sensitive manner. CD3‐positive T‐cells did not bind N/OFQ ATTO594 ; they did contain N/OFQ. Stimulation with CXCL12/IL‐6 increased N/OFQ release. When incubated with LPS/PepG, NOP surface expression was induced leading to N/OFQ ATTO594 binding. In LPS/PepG‐treated cells, N/OFQ reduced migration to CXCL12/IL‐6. LPS/PepG increased GM‐CSF release in an N/OFQ sensitive manner. Conclusions and Implications We suggest both a constitutive and sepsis‐inducible N/OFQ‐NOP receptor autocrine regulation of B‐ and T‐cell function, respectively. These NOP receptors variably inhibit migration and reduce GM‐CSF release. These data provide mechanistic insights to the detrimental role for increased N/OFQ signalling in sepsis and suggest a potential role for NOP antagonists as treatments.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Leicester, UK.
- Cellomatics Biosciences Ltd, Nottingham, UK.
- Molecular and Cell Biology, University of Leicester, Leicester, UK.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy.
ORCID profiles: Jonathon Mark Willets, Jonathan P Thompson, Remo Guerrini, Girolamo Calo, David G Lambert
Funding
- Biotechnology and Biological Sciences Research Council
Cite
APA
Bird, M. F., Hebbes, C. P., Tamang, A., Willets, J. M., Thompson, J. P., Guerrini, R., Calo, G., & Lambert, D. G. (2023). In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells. British Journal of Pharmacology. https://doi.org/10.1111/bph.16088
Vancouver
Bird MF, Hebbes CP, Tamang A, Willets JM, Thompson JP, Guerrini R, et al. In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells. British Journal of Pharmacology. 2023. doi:10.1111/bph.16088
BibTeX
@article{Bird2023,
author = {Bird, Mark F and Hebbes, Christopher P and Tamang, Anushuya and Willets, Jonathon Mark and Thompson, Jonathan P and Guerrini, Remo and Calo, Girolamo and Lambert, David G},
title = {In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells},
journal = {British Journal of Pharmacology},
year = {2023},
doi = {10.1111/bph.16088}
}
EUVIMED